...
首页> 外文期刊>Medicinal chemistry >Intra - and Intercellular Calcium Handling in Pulmonary Arterial Hypertension
【24h】

Intra - and Intercellular Calcium Handling in Pulmonary Arterial Hypertension

机译:肺动脉高压中细胞内和细胞间钙的处理

获取原文
获取原文并翻译 | 示例

摘要

Pulmonary arterial hypertension (PAH) is a serious life threatening disease that leads to right heart failure and death. Elevated pulmonary vascular resistance (PVR) is the main pathophysiological component that leads to elevated pulmonary arterial pressures and increased right ventricular afterload. Increased PVR is related to different mechanisms that include vasoconstriction, proliferative and obstructive remodeling of the pulmonary vessel wall and in situ thrombosis. Numerous molecular, genetic and humoral abnormalities have been proposed to play an important role in pulmonary vasoconstriction and remodeling. Of those, calcium (Ca+2) is a well recognized parameter involved in the pathogenetic mechanisms of PAH, because of its twofold role in both vasoconstriction and pulmonary artery smooth muscle cell (PASMC) proliferation. The aim of this review is to focus on Ca+2 handling and dysregulation in PASMC of PAH patients.
机译:肺动脉高压(PAH)是一种严重的威胁生命的疾病,可导致右心衰竭和死亡。肺血管阻力(PVR)升高是导致肺动脉压升高和右心室后负荷增加的主要病理生理成分。 PVR升高与不同机制有关,包括血管收缩,肺血管壁增生性和阻塞性重构以及原位血栓形成。已经提出了许多分子,遗传和体液异常在肺血管收缩和重塑中起重要作用。其中,钙(Ca + 2)是PAH致病机制中公认的参数,因为它在血管收缩和肺动脉平滑肌细胞(PASMC)增殖中都有双重作用。这篇综述的目的是着重于PAH患者PASMC中Ca + 2的处理和失调。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号